Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, GLP-1RA, SGLT2i Apr 19 | 2021April 19-22 CHMP Agenda; EMPEROR-REDUCED Opinion?; Virta Health Raises $133M in Series EPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Apr 19 | 2021Insulet Omnipod 5 Tale-of-the-tape AnalysisPurchase Blast
$599
Posted in: Glucose Monitoring Apr 05 | 2021Dexcom and Welldoc Expand Partnership for T2DMPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Mar 29 | 2021New Medtronic/InPen MDI Basal+Bolus Advisement Connected SystemPurchase Blast
astrazeneca cover image
$599
Posted in: Dual/triple agonist, Other, SGLT2i Mar 25 | 2021Meet AZ Management Investor Event HighlightsPurchase Blast
1 2 3 54

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.